Supercom Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of March 2023 for Supercom Ltd., a foreign private issuer headquartered in Tel Aviv, Israel. The filing discloses a material corporate event: a registered direct offering and concurrent private placement of equity securities to a single accredited institutional investor.
Key Financial Metrics and Transaction Details
The filing details a capital raise transaction rather than standard operating financial results. Key transaction metrics include:
- Securities Issued: 485,000 ordinary shares and 1,032,615 registered pre-funded warrants.
- Private Warrants: 1,517,615 private warrants issued in a concurrent private placement.
- Purchase Price: $1.60 per share (combined with private warrant) and $1.59999 per pre-funded warrant (combined with private warrant).
- Warrant Exercise Prices: $0.00001 for pre-funded warrants; $1.66 for private warrants.
- Placement Agent Fee: 6% of gross proceeds paid to Maxim Group LLC.
The filing text does not provide clear values for revenue, profit, cash flow, operating margins, total debt, or liquidity positions for the period.
Material Changes and Amendments
In connection with the closing of the offering, the Company agreed to amend existing warrants previously issued to the Purchaser on July 27, 2022. The exercise price for these 564,869 warrants was reduced from $3.08 per share to $1.66 per share.
Guidance, Outlook, and Restrictions
The Company expects the offering to close on or about March 31, 2023. Under the Purchase Agreement, the Company has agreed to a 60-day lock-up period following the closing date, during which it will not issue any ordinary shares or equivalents or file new registration statements, subject to certain exceptions. The Company is obligated to file a registration statement for the resale of warrant shares within 45 days of the agreement date.
Investor Verification Checklist
- Verify the final closing date and total gross proceeds received from the offering.
- Confirm the dilution impact of the 485,000 new shares and 1,032,615 pre-funded warrants on existing shareholders.
- Review the amended terms of the 564,869 existing warrants to confirm the exercise price reduction to $1.66.
- Assess the Company's cash position post-closing to determine runway for operations.
- Monitor the 60-day lock-up period expiration for potential future equity issuance.